Global Health Ltd

AI
Global Health Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Global Health Ltd

₹ 1,429 0.13%
11 Nov - close price
medanta.org BSE: 543654 NSE: MEDANTA
About

Global Health Limited operates a network of multi-specialty tertiary and quaternary care hospitals under the Medanta brand, primarily across North and East India. The company specialises in cardiac sciences, oncology, neurosciences, digestive and hepatobiliary sciences, orthopaedics, organ transplantation, kidney and urology, and other complex medical procedures. As of June 2026, Medanta operated six hospitals across Gurugram, Lucknow, Patna, Ranchi, Indore and Noida, supported by an expanding diagnostics, pharmacy and outpatient network. [1]

Key Points

Hospital Count
Global Health operates 6 hospitals across Gurugram, Indore, Ranchi, Lucknow, Patna and Noida, with 3,737 installed beds as of June 2026 across 5.6 million sq. ft. The network has 950+ ICU beds and offers services across 30+ medical specialties. Gurugram is the flagship hospital, while Lucknow, Patna and Noida form the newer hospital portfolio where capacity and clinical services are being scaled.[1]

Website BSE NSE
  • Market Cap ₹ 38,419 Cr.
  • Current Price ₹ 1,429
  • High / Low ₹ 1,544 / 955
  • Stock P/E 59.3
  • Book Value ₹ 161
  • Dividend Yield 0.03 %
  • ROCE 17.4 %
  • ROE 15.2 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company has delivered good profit growth of 80.7% CAGR over last 5 years

Cons

  • Stock is trading at 8.89 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of BSE 500 BSE Healthcare Nifty 500 BSE SmallCap Select Index BSE 150 MidCap Index

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
844 836 809 861 957 943 931 1,031 1,099 1,121 1,159 1,304 1,469
631 620 629 675 728 706 707 784 868 904 915 1,017 1,099
Operating Profit 213 216 179 186 228 238 225 247 231 217 244 287 370
OPM % 25% 26% 22% 22% 24% 25% 24% 24% 21% 19% 21% 22% 25%
21 18 27 22 18 16 -27 20 36 -15 37 22 24
Interest 20 18 18 18 16 16 15 14 17 22 27 27 28
Depreciation 43 44 45 47 49 48 49 45 50 61 67 69 71
Profit before tax 171 172 143 144 181 189 133 208 200 120 187 213 295
Tax % 27% 28% 11% 26% 28% 24% 24% 24% 21% 21% 24% 26% 26%
125 124 127 106 131 143 101 159 158 95 142 157 219
EPS in Rs 4.66 4.61 4.74 3.96 4.87 5.32 3.78 5.92 5.89 3.54 5.36 5.90 8.21
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
1,382 1,343 1,456 1,500 1,447 2,167 2,710 3,275 3,692 4,410 5,053
1,081 1,218 1,283 1,309 1,250 1,709 2,073 2,466 2,806 3,480 3,935
Operating Profit 301 125 172 192 197 458 637 809 886 930 1,118
OPM % 22% 9% 12% 13% 14% 21% 24% 25% 24% 21% 22%
45 49 50 44 31 39 49 75 29 98 68
Interest 14 28 38 57 73 86 86 84 74 90 103
Depreciation 70 86 102 115 123 130 150 173 194 223 267
Profit before tax 262 60 83 64 32 281 449 627 647 715 815
Tax % 35% 45% 38% 43% 11% 30% 27% 24% 26% 23%
170 33 51 36 29 196 326 478 481 554 613
EPS in Rs 7.02 1.36 2.09 1.47 1.16 7.75 12.16 17.81 17.92 20.70 23.01
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 2%
Compounded Sales Growth
10 Years: 12%
5 Years: 25%
3 Years: 18%
TTM: 26%
Compounded Profit Growth
10 Years: 13%
5 Years: 81%
3 Years: 19%
TTM: 11%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 15%
1 Year: 22%
Return on Equity
10 Years: %
5 Years: 16%
3 Years: 16%
Last Year: 15%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Equity Capital 48 48 49 49 50 51 54 54 54 54 54
Reserves 976 1,136 1,246 1,300 1,333 1,565 2,375 2,852 3,333 3,908 4,270
165 456 787 929 931 1,109 1,122 802 718 1,190 1,353
295 343 347 388 380 421 547 572 662 753 930
Total Liabilities 1,485 1,984 2,430 2,666 2,694 3,146 4,097 4,280 4,766 5,905 6,606
914 1,094 1,194 1,703 1,616 1,776 2,050 2,236 2,514 3,795 3,957
CWIP 12 317 666 382 464 439 327 388 533 132 207
Investments 0 0 0 0 0 0 0 0 3 3 3
559 573 570 581 615 930 1,720 1,656 1,716 1,975 2,440
Total Assets 1,485 1,984 2,430 2,666 2,694 3,146 4,097 4,280 4,766 5,905 6,606

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
228 63 166 175 242 311 645 612 624 714
-241 -69 -249 -87 -239 -421 -342 -441 -721 -1,089
-7 9 97 -1 -81 160 346 -514 -97 272
Net Cash Flow -20 3 14 87 -78 50 648 -343 -194 -103
Free Cash Flow 71 -81 -133 -13 100 38 409 335 110 -123
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 108% 93% 135% 121% 131% 89% 118% 98% 89% 90%

Ratios

Consolidated / View Standalone

Mar 2016 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 20 41 41 36 34 30 26 24 29 34
Inventory Days 28 26 26 43 42 36 35 32 28 29
Days Payable 92 124 142 147 138 90 114 90 81 89
Cash Conversion Cycle -45 -56 -75 -67 -62 -24 -52 -34 -24 -26
Working Capital Days -23 -33 -18 -31 -48 -20 -37 -32 -21 -7
ROCE % 6% 6% 5% 15% 17% 20% 20% 17%

Insights

In beta
Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
ALOS (Average Length of Stay)
days

Log in to view insights

Please log in to see hidden values.

Login
ARPOB (Average Revenue Per Occupied Bed)
INR
Bed Occupancy Rate
%
Census Beds (Operational Capacity)
count
In-Patient Volume (IPD)
count
Out-Patient Volume (OPD)
count
Total Beds (Installed Capacity)
count

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
33.05% 33.04% 33.04% 33.04% 33.03% 33.03% 33.01% 33.01% 33.01% 33.01% 33.00% 33.00%
11.36% 12.10% 12.94% 12.21% 12.48% 11.76% 11.54% 11.41% 10.54% 10.15% 9.46% 9.92%
11.15% 10.25% 10.57% 11.11% 10.51% 11.93% 12.20% 12.97% 13.99% 14.76% 16.89% 17.01%
44.45% 44.60% 43.44% 43.64% 43.98% 43.28% 43.19% 42.56% 42.41% 42.01% 40.55% 39.96%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.06% 0.06% 0.06% 0.08% 0.09% 0.12%
No. of Shareholders 1,24,7751,66,2531,55,3071,49,7221,48,6331,54,6881,56,3721,55,8061,51,2411,47,3901,40,5311,35,371

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls